Search research articles
Contact Us
Filters
Showing results (1-10 of 46) with videos related to
Page
of 5
Sort By:
Pharmaceutical Statistics
|
March 12, 2011
A note on dealing with missing standard errors in meta-analyses of continuous outcome measures in WinBUGS
John W Stevens
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
January 8, 2011
Uncertainty analysis is inherently Bayesian
John W Stevens
The British Journal of General Practice : the Journal of the Royal College of General Practitioners
|
December 31, 2009
NICE work: how NICE decides what we should pay for
John W Stevens
Pharmacoeconomics
|
June 22, 2018
Using Evidence from Randomised Controlled Trials in Economic Models: What Information is Relevant and is There a Minimum Amount of Sample Data Required to Make Decisions?
John W Stevens
Health Economics
|
December 17, 2002
Assessing and comparing costs: how robust are the bootstrap and methods based on asymptotic normality?
Anthony O'Hagan, John W Stevens
Journal of Health Economics
|
May 4, 2004
On estimators of medical costs with censored data
Anthony O'Hagan, John W Stevens
International Journal of Technology Assessment in Health Care
|
February 27, 2003
Incorporation of genuine prior information in cost-effectiveness analysis of clinical trial data
John W Stevens, Anthony O'Hagan
BMC Medical Research Methodology
|
March 27, 2002
The probability of cost-effectiveness
Anthony O'Hagan, John W Stevens
Pharmaceutical Statistics
|
December 3, 2011
Pharmaceutical Statistics 10th anniversary
Katherine Hutchinson, John W Stevens
Medical Decision Making : an International Journal of the Society for Medical Decision Making
|
March 30, 2018
Incorporating Genuine Prior Information about Between-Study Heterogeneity in Random Effects Pairwise and Network Meta-analyses
Shijie Ren, Jeremy E Oakley, John W Stevens
Page
of 5
Search research articles
Search
Showing results (1-10 of 46) with videos related to
Sort By:
Page
of 5
Pharmaceutical Statistics
|
March 12, 2011
A note on dealing with missing standard errors in meta-analyses of continuous outcome measures in WinBUGS
John W Stevens
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
January 8, 2011
Uncertainty analysis is inherently Bayesian
John W Stevens
The British Journal of General Practice : the Journal of the Royal College of General Practitioners
|
December 31, 2009
NICE work: how NICE decides what we should pay for
John W Stevens
Pharmacoeconomics
|
June 22, 2018
Using Evidence from Randomised Controlled Trials in Economic Models: What Information is Relevant and is There a Minimum Amount of Sample Data Required to Make Decisions?
John W Stevens
Health Economics
|
December 17, 2002
Assessing and comparing costs: how robust are the bootstrap and methods based on asymptotic normality?
Anthony O'Hagan, John W Stevens
Journal of Health Economics
|
May 4, 2004
On estimators of medical costs with censored data
Anthony O'Hagan, John W Stevens
International Journal of Technology Assessment in Health Care
|
February 27, 2003
Incorporation of genuine prior information in cost-effectiveness analysis of clinical trial data
John W Stevens, Anthony O'Hagan
BMC Medical Research Methodology
|
March 27, 2002
The probability of cost-effectiveness
Anthony O'Hagan, John W Stevens
Pharmaceutical Statistics
|
December 3, 2011
Pharmaceutical Statistics 10th anniversary
Katherine Hutchinson, John W Stevens
Medical Decision Making : an International Journal of the Society for Medical Decision Making
|
March 30, 2018
Incorporating Genuine Prior Information about Between-Study Heterogeneity in Random Effects Pairwise and Network Meta-analyses
Shijie Ren, Jeremy E Oakley, John W Stevens
Page
of 5